Suppr超能文献

医疗费用覆盖与高血压和糖尿病护理进展:马来西亚半农村社区的一项五年随访研究

Healthcare Cost Coverage and Hypertension and Diabetes Care Step Movement: A Five-Year Follow-Up Study in a Malaysian Semi-Rural Community.

作者信息

Folayan Adeola, Fatt Quek Kia, Cheong Mark Wing Loong, Su Tin Tin

机构信息

South East Asia Community Observatory (SEACO) and Global Public Health, Jeffrey Cheah School of Medicine and Health Sciences Monash University Malaysia Bandar Sunway Selangor Malaysia.

Global Public Health, Jeffrey Cheah School ofMedicine and Health Sciences Monash University Malaysia Bandar Sunway Selangor Malaysia.

出版信息

Health Sci Rep. 2025 May 19;8(5):e70740. doi: 10.1002/hsr2.70740. eCollection 2025 May.

Abstract

BACKGROUND AND AIMS

This study aims to understand how healthcare cost coverage (HCC) status affects hypertension and diabetes care across the three major care steps: awareness, treatment initiation and control.

METHODS

The probability of progressing the care steps was determined with logistic regression. The backward movements of two care steps (treatment and control) were investigated using McNemar's tests and presented with a Sankey diagram. All results were disintegrated by HCC status.

RESULT

There was no evidence that having HCC contributed to any care step progression. However, there was no significant backward movement for diabetes treatment and blood pressure control for those with HCC, while those without HCC had a significant backward movement for diabetes treatment (54.3% [152/280],  < 0.001) and blood pressure control (31.6% [43/136],  = 0.04).

CONCLUSION

Our results suggest that HCC supported a reduction in backward movement for some care steps but did not contribute to care step progression. HCC policies should aim to progress enrolees from awareness to initiating treatment and achieving control to attaining long-term hypertension and diabetes control in low- and middle-income countries.

摘要

背景与目的

本研究旨在了解医疗费用覆盖(HCC)状况如何影响高血压和糖尿病在三个主要治疗阶段的治疗情况,这三个阶段分别为知晓、开始治疗和病情控制。

方法

采用逻辑回归确定治疗阶段进展的概率。使用麦克尼马尔检验研究两个治疗阶段(治疗和控制)的逆向进展情况,并用桑基图展示。所有结果均按HCC状况进行分解。

结果

没有证据表明拥有HCC有助于任何治疗阶段的进展。然而,对于患有HCC的患者,糖尿病治疗和血压控制没有明显的逆向进展,而没有HCC的患者在糖尿病治疗(54.3%[152/280],<0.001)和血压控制(31.6%[43/136],=0.04)方面有明显的逆向进展。

结论

我们的研究结果表明,HCC有助于减少某些治疗阶段的逆向进展,但对治疗阶段的进展没有帮助。在低收入和中等收入国家,HCC政策应旨在使参保者从知晓病情进展到开始治疗,并实现控制,以达到长期控制高血压和糖尿病的目的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd77/12086813/53d73837f277/HSR2-8-e70740-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验